Legal & General Group
UPB

Legal & General Group’s Upstream Bio Inc UPB Stock Holding History

Legal & General Group’s Portfolio UPB Stock Details UPB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.5K Sell
9,609
-4,100
-30% -$73.8K ﹤0.01% 2622
2025
Q4 		$372K Buy
13,709
+10,785
+369% +$268K ﹤0.01% 2495
2025
Q3 		$55K Sell
2,924
-250
-8% -$3.88K ﹤0.01% 2712
2025
Q2 		$34.9K Buy
3,174
+1,440
+83% +$13.3K ﹤0.01% 2795
2025
Q1 		$10.6K Hold
1,734
– – ﹤0.01% 3157
2024
Q4 		$28.5K Buy
+1,734
New +$38.7K ﹤0.01% 2905

Other funds holding UPB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Legal & General Group's UPB Position: Q1 2026 in Review

Legal & General Group reduced its Upstream Bio Inc (UPB) stake by 30% in Q1 2026, selling an estimated $73.8K and leaving 9,609 shares worth $86.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2622.

Legal & General Group first reported a position in UPB in Q4 2024 and has held it in 6 quarters since. The position peaked at $372K in Q4 2025. 140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Legal & General Group held 9,609 shares of Upstream Bio Inc worth $86.5K as of Q1 2026.
  • Legal & General Group sold 4,100 Upstream Bio Inc shares in Q1 2026, an estimated $73.8K.
  • Upstream Bio Inc made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2622 holding.
  • Legal & General Group first reported a position in Upstream Bio Inc in Q4 2024 and has held it in 6 quarters since.
  • Legal & General Group's Upstream Bio Inc position peaked at $372K in Q4 2025.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.